首页> 外国专利> A sustained-release lipid pre-concentrate and a sustained-release injectable pharmaceutical composition in the form of lipid solution comprising the same

A sustained-release lipid pre-concentrate and a sustained-release injectable pharmaceutical composition in the form of lipid solution comprising the same

机译:缓释脂质预浓缩物和包含其的脂质溶液形式的缓释注射药物组合物

摘要

The present invention has 14 to 20 carbon atoms (C 14 to C 20 ) unsaturated fatty acids; Phospholipids; And a sustained-release lipid precursor formulation in the form of a lipid solution comprising α-tocopherol acetate, which does not contain diacyl glycerol and sorbitan unsaturated fatty acid ester; A precursor formulation that forms liquid crystals in an aqueous medium is provided. In addition, the present invention provides a pharmaceutical composition for sustained-release injection in the form of a lipid solution containing the precursor and a pharmacologically active substance, which does not contain diacyl glycerol and sorbitan unsaturated fatty acid ester.
机译:本发明具有14至20个碳原子(C 14 至C 20 )不饱和脂肪酸。磷脂;以及包含α-生育酚乙酸酯的脂质溶液形式的缓释脂质前体制剂,其不含二酰基甘油和脱水山梨醇不饱和脂肪酸酯;提供了在水性介质中形成液晶的前体制剂。另外,本发明提供了脂质溶液形式的用于持续释放注射的药物组合物,其包含前体和药理活性物质,其不含二酰基甘油和脱水山梨醇不饱和脂肪酸酯。

著录项

  • 公开/公告号KR20200100392A

    专利类型

  • 公开/公告日2020-08-26

    原文格式PDF

  • 申请/专利权人 (주)아이엠디팜;

    申请/专利号KR20190018619

  • 发明设计人 박영준;전상원;최숙;

    申请日2019-02-18

  • 分类号A61K9;A61K38/08;A61K38/09;A61K47/12;A61K47/14;A61K47/22;A61K47/24;

  • 国家 KR

  • 入库时间 2022-08-21 11:06:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号